financetom
Business
financetom
/
Business
/
Tokyo Gas expects net profit to nearly double in FY25/26
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tokyo Gas expects net profit to nearly double in FY25/26
Mar 26, 2025 4:21 AM

*

Plans to buyback shares of up to Y120 bln in

April-September

*

May invest in promising shale gas assets in North America

*

Will consider selling Y100 bln real estate by March 2029

(Adds president quotes and details in paragraph 8-12, and

bullets)

By Yuka Obayashi and Katya Golubkova

TOKYO, March 26 (Reuters) - Tokyo Gas ( TKGSF ) aims to

nearly double its net profit in the 2025/26 fiscal year and

plans to expand in the United States, Japan's biggest city gas

provider said on Wednesday.

The company said it expects net profit to grow to 131

billion yen ($871 million) in the 2025/2026 fiscal year, which

begins on April 1, from 72 billion yen for the year ending this

month. It sees its dividend rising by 10 yen to 80 yen per share

in the current fiscal year.

It also plans a new share buyback of up to 120 billion yen

in the first half of the 25/26 fiscal year, it said.

Tokyo Gas ( TKGSF ) said it wants to increase coordination between its

liquefied natural gas trading and shale gas businesses in the

United States and expand there, while also building its LNG

trading worldwide, mainly through Singapore and London.

"Our shale gas business is expected to become a major profit

pillar in FY25/26," the company's statement said.

The company also outlined its basic policy for formulating a

new 3-year business plan starting in April 2026.

During this period, it aims to invest over 1.1 trillion yen

and plans shareholder returns of over 200 billion yen. It may

also sell around 100 billion yen worth of real estate, it said.

Tokyo Gas ( TKGSF ), which acquired U.S.-based natural gas producer

Rockcliff Energy in 2023, plans to spend at least $1.9 billion

on its U.S. shale business during the three years to March 2029.

"By concentrating in the Haynesville area, we have been able

to lower costs by sharing pipelines, making us one of the most

cost competitive in the region," President Shinichi Sasayama

told a press conference, adding that it may consider investing

in promising shale gas assets in North America.

Asked about interest in buying LNG from the Alaska LNG

project, Sasayama declined to comment, citing a lack of details

such as pricing and contract conditions.

He said decisions on real estate sales in Japan would be

based on synergies with the energy business and overall economic

viability but gave no specific examples of potential asset

sales.

Sasayama also declined to comment on U.S. activist

investor Elliott Management, which bought a 5.03% stake in Tokyo

Gas ( TKGSF ) and has urged it to divest parts of its extensive real

estate portfolio to boost shareholder value.

Tokyo Gas ( TKGSF ) shares closed 2% down in Tokyo.

($1 = 150.4700 yen)

(Reporting by Katya Golubkova and Yuka Obayashi; Editing by

Sonali Paul and Ros Russell)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Andlauer Healthcare to Launch Normal Course Issuer Bid
Andlauer Healthcare to Launch Normal Course Issuer Bid
Jun 27, 2024
09:00 AM EDT, 06/27/2024 (MT Newswires) -- Andlauer Healthcare Group ( ANDHF ) said Thursday that it secured TSX approval for a normal course issuer bid (NCIB) for up to 10% of its public float over the next 12 months. The company said it can purchase its shares for cancellation beginning on July 2 and until July 1, 2025. Andlauer...
Verona Pharma's inhaled COPD therapy to be priced at $2,950 per month
Verona Pharma's inhaled COPD therapy to be priced at $2,950 per month
Jun 27, 2024
June 27 (Reuters) - Verona Pharma's therapy for treating a chronic lung disease will be sold in the U.S. at a wholesale price of $2,950 per month, the U.K.-based company said on a conference call on Thursday. The U.S. health regulator's assent on Wednesday for the therapy, branded as Ohtuvayre, provides a new inhaled non-steroidal treatment for chronic obstructive pulmonary...
Clarke Secures Approval to Renew Normal Course Issuer Bid
Clarke Secures Approval to Renew Normal Course Issuer Bid
Jun 27, 2024
09:01 AM EDT, 06/27/2024 (MT Newswires) -- Clarke (CKI.TO), an investment and real estate company, said on Thursday that it has secured approval for the renewal of the normal course issuer bid. Under the bid, the company plans to buy up to 697,592 common shares, representing 5% of the total 14 million issued and outstanding common shares as of June...
Spice maker McCormick beats quarterly results on strong EMEA business
Spice maker McCormick beats quarterly results on strong EMEA business
Jun 27, 2024
(Reuters) - McCormick ( MKC ) beat market expectations for second-quarter profit and sales on Thursday, led by strong demand for its spices and seasonings in Europe, Middle East and Africa. Customers grappling with still-high costs preferred cooking at home to dining out, improving volumes across the company's consumer segment, its biggest unit. Consumer sales in Europe, Middle East and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved